Data / Form D filings / Converge Bio Inc.
Converge Bio Inc.: Form D filing
Converge Bio Inc., a biotechnology company in Claymont, DE, filed a Form D with the SEC in 2026. The latest, on April 28, 2026, reports $25 million sold of a $25 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2093 PHILADELPHIA PIKE #1664, Claymont, DE, 19703
- Phone
- (617) 351-8116
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2131104
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | New notice | $25,000,000 | $25,000,000 | 19 | Sep 24, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dov Gertz | Executive Officer, Director | |
| Oded Kalev | Executive Officer, Director | |
| Shahar Tzafrir | Director | |
| Andrew Hedin | Director | |
| Iddo Weiner | Executive Officer |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Apr 27, 2026 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Converge Bio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.